Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up-Reference-Cited by-同舟云学术

Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up

Published:1999-04 Issue:1 Volume:51 Page:35-42
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Reinders Janny G.,Heijmen Ben J.M.,Olofsen-van Acht Manouk J.J.,van Putten Wim L.J.,Levendag Peter C.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference36 articles.

1. Late cardiopulmonary toxicity after treatment for Hodgkin's disease;Allavena;Br. J. Cancer,1992

2. Long-term cardiovascular evaluation of patients with Hodgkin's disease treated by thoracic mantle radiation therapy;Applefeld;Cancer Treat. Rep.,1982

3. Coronary artery disease mortality in patients treated for Hodgkin's disease;Boivin;Cancer,1992

4. A re-analysis of available dose-response and time-dose data in Hodgkin's disease;Brincker;Radiother. Oncol.,1994

5. Analysis of 16 young (aged 15 to 33) years necropsy patients who received over 3500 rads to the heart;Brosius;Am. J. Med.,1981

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lifetime evaluation of left ventricular structure and function in male ApoE null mice after gamma and space-type radiation exposure;Frontiers in Physiology;2023-11-20

2. Radiation therapy cardiovascular risks;Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease;2023

3. Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors;Acta Oncologica;2022-09-02

4. Impaired Global Longitudinal Strain Is Associated with Cardiovascular Events in Hodgkin Lymphoma Survivors;Cancers;2022-05-08

5. Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group;European Journal of Cancer;2021-10